目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION
FIGURE 2 MICROCATHETERS MARKET, BY REGION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 STUDY LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS

3 EXECUTIVE SUMMARY (Page No. - 37)
FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION)
FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

4 PREMIUM INSIGHTS (Page No. - 41)
4.1 MICROCATHETERS MARKET OVERVIEW
FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND
4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT
FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET
4.3 MICROCATHETERS MARKET SHARE, BY END USER
FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET
FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 2022-2027

5 MARKET OVERVIEW (Page No. - 44)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Technological advancements in interventional cardiology
5.2.1.2 Expansion of patient population suffering from chronic illness
5.2.1.3 Increasing conferences and symposia to spread awareness about benefits of microcatheters
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory guidelines and high cost of drug approval
5.2.2.2 Lack of awareness about microcatheters in underdeveloped or emerging countries
5.2.3 OPPORTUNITIES
5.2.3.1 Rising number of patients suffering from chronic diseases and cancer globally
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET
TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 OVERVIEW
TABLE 3 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.2 THREAT OF NEW ENTRANTS
5.4.3 THREAT OF SUBSTITUTES
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 BARGAINING POWER OF BUYERS
5.4.6 DEGREE OF COMPETITION
5.5 REGULATORY ANALYSIS
5.5.1 US
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 JAPAN
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6 REIMBURSEMENT ANALYSIS
TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS
5.7 ECOSYSTEM ANALYSIS
5.8 VALUE CHAIN ANALYSIS
5.8.1 RESEARCH AND DEVELOPMENT
5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 21 VALUE CHAIN ANALYSIS
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED COMPANIES
5.9.3 END USERS
FIGURE 22 SUPPLY CHAIN ANALYSIS
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020-2022 (USD MILLION)
TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020-2022 (USD MILLION)
5.12 KEY CONFERENCES AND EVENTS IN 2022-2023
TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX

6 MICROCATHETER MARKET, BY PRODUCT (Page No. - 58)
6.1 INTRODUCTION
TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 12 MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
6.2 DELIVERY MICROCATHETERS
6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET
TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
6.3 ASPIRATION MICROCATHETERS
6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET
TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
6.4 DIAGNOSTICS MICROCATHETERS
6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET
TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
6.5 STEERABLE MICROCATHETERS
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET
TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)

7 MICROCATHETERS MARKET, BY PRODUCT DESIGN (Page No. - 69)
7.1 INTRODUCTION
TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
7.2 SINGLE LUMEN MICROCATHETERS
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET
TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)
7.3 DUAL-LUMEN MICROCATHETERS
7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET
TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)

8 MICROCATHETERS MARKET, BY APPLICATION (Page No. - 73)
8.1 INTRODUCTION
TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
8.2 CARDIOVASCULAR APPLICATIONS
8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET
TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
8.3 NEUROVASCULAR APPLICATIONS
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET
TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
8.4 PERIPHERAL VASCULAR APPLICATION
8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET
TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
8.5 ONCOLOGY APPLICATIONS
8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET
TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

9 MICROCATHETERS MARKET, BY END USER (Page No. - 79)
9.1 INTRODUCTION
TABLE 38 MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET
TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020-2027 (USD MILLION)
9.3 AMBULATORY CARE CENTERS
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION
TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020-2027 (USD MILLION)

10 MICROCATHETERS MARKET, BY REGION (Page No. - 83)
10.1 INTRODUCTION
TABLE 41 MICROCATHETERS MARKET, BY REGION, 2020-2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing prevalence of target diseases and high demand for timely diagnosis to propel market
TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.3 EUROPE
TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Increasing aging population and rising life expectancy to boost market
TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Significant evolution of healthcare sector to drive market
TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.3.3 UK
10.3.3.1 High burden of chronic diseases and large volume of surgeries to augment market
TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing geriatric population to aid growth
TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing technological developments in healthcare sector to propel market
TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing geriatric population and surgical procedures to drive market
TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth
TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market
TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market
TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Growing target patient population for cardiovascular diseases to drive market
TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET
TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET
TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020-2027 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 107)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET
11.3 MARKET RANKING ANALYSIS
FIGURE 27 MICROCATHETERS MARKET (2021)
11.3.1 BOSTON SCIENTIFIC CORPORATION
11.3.2 ASAHI INTECC CO., LTD.
11.3.3 MEDTRONIC PLC
11.3.4 TELEFLEX
11.3.5 TERUMO MEDICAL CORPORATION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET
11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
TABLE 80 OVERALL FOOTPRINT OF COMPANIES
TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES)
11.6 COMPANY EVALUATION QUADRANT
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
11.7 START-UPS/SMES EVALUATION QUADRANT
11.7.1 PROGRESSIVE COMPANIES
11.7.2 DYNAMIC COMPANIES
11.7.3 STARTING BLOCKS
11.7.4 RESPONSIVE COMPANIES
FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021)
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 2019-2022
11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019-2022

12 COMPANY PROFILES (Page No. - 122)
(Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
12.1 KEY PLAYERS
12.1.1 BOSTON SCIENTIFIC CORPORATION
TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021)
12.1.2 ASAHI INTECC CO., LTD.
TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW
FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021)
12.1.3 MEDTRONIC PLC
TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021)
12.1.4 STRYKER
TABLE 89 STRYKER: COMPANY OVERVIEW
FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021)
12.1.5 BECTON, DICKINSON AND COMPANY
TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.1.6 TERUMO MEDICAL CORPORATION
TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW
FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.7 MERIT MEDICAL SYSTEMS, INC.
TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021)
12.1.8 CARDINAL HEALTH
TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
12.1.9 B. BRAUN MELSUNGEN AG
TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
12.1.10 COOK MEDICAL GROUP
TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW
12.1.11 TELEFLEX
TABLE 96 TELEFLEX: COMPANY OVERVIEW
12.1.12 JOHNSON & JOHNSON
TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW
12.1.13 ANGIODYNAMICS
TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW
12.1.14 PENUMBRA
TABLE 99 PENUMBRA: COMPANY OVERVIEW
12.1.15 BTG PLC
TABLE 100 BTG PLC: COMPANY OVERVIEW
12.1.16 GUERBET LLC
TABLE 101 GUERBET LLC: COMPANY OVERVIEW
12.1.17 EMBOLX INC.
TABLE 102 EMBOLX INC.: COMPANY OVERVIEW
12.1.18 TOKAI MEDICAL
TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW
12.1.19 KANEKA CORPORATION
TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT
12.1.20 INTEGER HOLDINGS CORPORATION
TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD.
TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
12.1.22 MICROVENTION TERUMO
TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW
12.1.23 REFLOW MEDICAL
TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW
12.1.24 SPARTAN MICRO
TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW
12.1.25 TRANSIT SCIENTIFIC
TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW
12.1.26 TRISALUS LIFE SCIENCES, INC.
TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW